TFA Therapeutics (RAJAF) Inventory (2020 - 2025)

TFA Therapeutics has reported Inventory for 5 years, with the latest figure at $674196.0 in Q4 2025.

• On a quarterly basis, Inventory changed N/A year-over-year to $674196.0 in Q4 2025; TTM through Dec 2025 was $674196.0, a N/A change from a year earlier, with the FY2025 full-year figure at $674196.0, changed N/A from the prior year.
• Inventory was $674196.0 for Q4 2025 at TFA Therapeutics, up from $4308.0 in the prior quarter.
• The five-year high for Inventory was $674196.0 in Q4 2025, with the low at $4308.0 in Q3 2023.
• Average Inventory over 4 years is $368096.5, with a median of $396941.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Inventory decreased 29.92% in 2021, then tumbled 34.73% in 2022.
• Over 4 years, Inventory stood at $480352.0 in 2021, then slumped by 34.73% to $313530.0 in 2022, then tumbled by 98.63% to $4308.0 in 2023, then soared by 15549.86% to $674196.0 in 2025.
• The last three Inventory figures came in at $674196.0 (Q4 2025), $4308.0 (Q3 2023), and $313530.0 (Q4 2022), per Business Quant data.